These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2814516)

  • 21. Thrombolysis in acute myocardial infarction.
    Satler LF; Kent KM; Green CE; Pearle DL; Pallas RS; Del Negro AA; Rackley CE
    Cardiovasc Clin; 1986; 16(3):39-52. PubMed ID: 3530483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defibrotide: a review on clinical use and future development.
    Larocca A; Cavallo F; Magarotto V; Rossi D; Patriarca F; Boccadoro M; Palumbo A
    Expert Opin Biol Ther; 2008 Aug; 8(8):1201-12. PubMed ID: 18613771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the efficacy of profibrinolytic treatment with defibrotide in the therapy of thrombophlebitis].
    Murgiano GA
    Clin Ter; 1988 Dec; 127(5):355-61. PubMed ID: 2976633
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient selection issues in the use of thrombolytic therapy in patients with acute myocardial infarction.
    Gore JM
    Z Kardiol; 1993; 82 Suppl 2():143-6. PubMed ID: 8328193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodologic aspects of intracoronary thrombolysis. Drugs, dosage and duration.
    Cowley MJ
    Circulation; 1983 Aug; 68(2 Pt 2):I90-5. PubMed ID: 6222849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality reperfusion therapy for acute myocardial infarction.
    Cannon CP
    Am Heart J; 2000 Nov; 140(5):707-16. PubMed ID: 11054614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The postoperative prevention of deep venous thrombosis and pulmonary embolism with defibrotide versus heparin-calcium: a randomized clinical multicenter study of 1296 patients undergoing major abdominal surgery].
    Di Somma C; Canepa G; Gipponi M; Frascio M
    Ann Ital Chir; 1992; 63(1):83-8. PubMed ID: 1605451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic reperfusion strategies for the treatment of ST-segment elevation myocardial infarction.
    Young JJ; Kereiakes DJ
    Rev Cardiovasc Med; 2003; 4(4):216-27. PubMed ID: 14668689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolytic therapy for acute myocardial infarction.
    Ross AM
    Cardiovasc Clin; 1989; 20(1):209-18. PubMed ID: 2653634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defibrotide protects rabbit myocardium from ischemia: relationship with the eicosanoid system.
    Berti F; Rossini G; Omini C; Daffonchio L; Tondo C; Cali G
    Pol J Pharmacol Pharm; 1987; 39(5):657-65. PubMed ID: 3506734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction.
    Korotkov A; Kistauri A; Korotkova A; Jibladze M; Guchua E
    Georgian Med News; 2006 Nov; (140):54-62. PubMed ID: 17179590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of defibrotide on infarct size and regional myocardial blood flow on the ischaemic reperfused rabbit heart.
    Thiemermann C; Thomas GR; Vane JR
    Prog Clin Biol Res; 1989; 301():131-5. PubMed ID: 2798443
    [No Abstract]   [Full Text] [Related]  

  • 36. [The value of late thrombolytic perfusion in acute myocardial infarct].
    Gulba DC
    Z Kardiol; 1993; 82 Suppl 2():183-5. PubMed ID: 8328200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 38. Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.
    Greenbaum AB; Ohman EM; Gibson CM; Borzak S; Stebbins AL; Lu M; Le May MR; Stankowski JE; Emanuelsson H; Weaver WD
    Am Heart J; 2007 Oct; 154(4):702-9. PubMed ID: 17892995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter clinical trial using an accelerated streptokinase regimen in patients with acute myocardial infarction.
    Xu C; Zhang T
    Chin Med J (Engl); 2000 Aug; 113(8):733-6. PubMed ID: 11776059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.